Restrictions imposed by the COVID-19 pandemic have required medical educators to reimagine nearly each side of undergraduate medical coaching, together with curriculum supply and assessments in a brief timeline. In this private view article, govt members of the University of Toronto medical pupil authorities and Faculty leads of pre-clerkship and clerkship education spotlight 5 sensible methods by which a student-Faculty partnership enabled the fast and clean adaptation of curricula during the COVID-19 pandemic.
These included involving college students as companions in choice making to contribute learner views early, agile and collaborative assembly buildings, frequent and constant communication with the coed physique, offering learners with Faculty views from the frontlines, and placing a stability within the degree of suggestions collected from college students. These methods could also be of utility to medical directors, educators, and pupil leaders in future crises affecting medical learners.
Two many years of little change: An evaluation of U.S. medical college primary science school by intercourse, race/ethnicity, and educational rank
To look at modifications in U.S. medical college primary science school over the past 20 years (1998-2018), we undertook an observational research using knowledge from the American Association of Medical Colleges Faculty Roster. Rank (Instructor, Assistant Professor, Associate Professor, and Professor), intercourse (Female), and race/ethnicity (Asian, Black or African American, Hispanic, Latino, Spanish Origin, or Multiple Race-Hispanic, and White) had been analyzed; this mirrored a inhabitants of 14,047 (1998) to 18,601 (2018) school. Summary p.c of school in varied gender, race/ethnicity origin classes had been analyzed throughout years of the research utilizing regression fashions.
We discovered that females (24.47% to 35.32%) had been underrepresented in any respect timepoints and a minority of school recognized as Black or African American (1.57% to 1.99%), Hispanic, Latino, Spanish Origin, or Multiple Race-Hispanic (3.03% to 4.44%), or Asian (10.90% to 20.41%). The largest inhabitants in any respect time factors was White Male Professors (30.53% to 20.85%), adopted by White Male Associate Professors (15.67% to 9.34%), and White Male Assistant Professors (13.22% to 9.75%). Small statistically vital will increase had been noticed amongst feminine school and college at a number of ranks who recognized as Black or African American or Hispanic, Latino, Spanish Origin, or Multiple Race-Hispanic.
We then accomplished secondary analyses trying on the interplay of race/ethnicity and Gender. We discovered: (1) a major enhance (p<0.0001) in each genders who establish as Asian though males had the next fee of enhance (6 level distinction, p<0.0001); (2) a major enhance for Black or African American females (P<0.01) not discovered amongst males; (3) vital will increase (p<0.0001) amongst each genders of school who establish as Hispanic, Latino, Spanish Origin, or Multiple Race-Hispanic though females had an roughly 1% increased fee of enhance; and (4) amongst school who establish as White, males had a major lower (p<0.0001) whereas females demonstrated an enhance (p<0.0001).
Tobacco use and attitudes on tobacco management amongst school members of a medical college in Northern Cyprus (tobacco use amongst medical academics)
The smoking prevalence of medical school members has not been a topic of analysis as incessantly as physicians and medical college students. The goal of this research was to find out the standing of tobacco use and a few attitudes amongst medical school members of a Northern Cyprus college. The knowledge had been collected by a questionnaire of 22 questions, developed in compliance with WHO tips.
The knowledge had been analyzed utilizing IBM-SPSS 23.Zero with p < .05 evaluated as vital. For this cross-sectional research, 128 members of the 146 lecturers responded (response fee of 87.7%). Lifetime smoking frequency was 46.9%. Current people who smoke comprised 21.9% whereas 7.0% consumed non-cigarette merchandise with total tobacco use of 26.6%. Of the people who smoke, 52.9% had began smoking at medical college.
Regarding docs being nonsmoking position fashions, constructive attitudes had been expressed considerably extra by non-smokers than people who smoke. Only 33.8% had been masking tobacco management of their instructing applications whereas 86.5% had constructive attitudes for complete tobacco management within the curriculum. The medical school members had a comparatively excessive frequency of tobacco use and the tobacco concern didn’t have ample content material within the education applications. Promisingly, the bulk of the medical school members had been in a supportive angle for complete tobacco management education.
The Views of Medical Faculty Students in Turkey Concerning the COVID-19 Pandemic.
The goal of this research was to elicit the views of medical school college students relating to the COVID-19 pandemic. This descriptive research was carried out with Ondokuz Mayıs University Medical Faculty college students on 24-27 March, 2020. The Medical Faculty presently has 2051 college students. A questionnaire was used as a knowledge assortment instrument. For that function, the authors designed a questionnaire particularly for this analysis through the “Google Forms” internet. This consisted of 40 open- and close-ended questions. The questionnaire was accomplished by 1375 (67.1%) college students. Accordingly, 52.4% of medical college students reported feeling mentally unwell.
Although 50.8% of medical college students reported typically/normally acquiring details about COVID-19 via the social media, 82.0% didn’t belief info/messages arriving via the social media and WhatsApp. We discovered that 86.7% of college students regarded frequent hand washing as crucial means of safety in opposition to COVID-19, and 19.3% of college students didn’t regard the COVID-19 pandemic as a extreme public well being drawback for Turkey at that second. In addition, 61.6% of college students said {that a} suppression technique involving tight restrictions have to be utilized to being the pandemic underneath management in Turkey.
 ExoStd? PC3 Fluorescent Exosome Standard |
|
M1086-100 |
Biovision |
|
EUR 756 |
 ExoStd? DAUD1 Fluorescent Exosome Standard |
|
M1088-100 |
Biovision |
|
EUR 756 |
 ExoStd? A549 Fluorescent Exosome Standard |
|
M1089-100 |
Biovision |
|
EUR 756 |
 ExoStd? B16F10 Fluorescent Exosome Standard |
|
M1159-100 |
Biovision |
|
EUR 773 |
) ExoStd? Lyophilized Exosome Standard (30 µg, Human Plasma, 2 vials) |
|
M1040-2 |
Biovision |
|
EUR 593 |
) ExoStd? Lyophilized Exosome Standard (30 µg, Human Plasma, 4 vials) |
|
M1040-4 |
Biovision |
|
EUR 909 |
) ExoStd? Lyophilized Exosome Standard (30 µg, Human Plasma, 6 vials) |
|
M1040-6 |
Biovision |
|
EUR 1300 |
) ExoStd? Lyophilized Exosome Standard (100 µg, Human Plasma, 2 vials) |
|
M1041-2 |
Biovision |
|
EUR 711 |
) ExoStd? Lyophilized Exosome Standard (100 µg, Human Plasma, 4 vials) |
|
M1041-4 |
Biovision |
|
EUR 1137 |
) ExoStd? Lyophilized Exosome Standard (100 µg, Human Plasma, 6 vials) |
|
M1041-6 |
Biovision |
|
EUR 1572 |
) ExoStd? Lyophilized Exosome Standard (30 µg, Human Serum, 2 vials) |
|
M1042-2 |
Biovision |
|
EUR 599 |
) ExoStd? Lyophilized Exosome Standard (30 µg, Human Serum, 4 vials) |
|
M1042-4 |
Biovision |
|
EUR 909 |
) ExoStd? Lyophilized Exosome Standard (30 µg, Human Serum, 6 vials) |
|
M1042-6 |
Biovision |
|
EUR 1300 |
) ExoStd? Lyophilized Exosome Standard (100 µg, Human Serum, 2 vials) |
|
M1043-2 |
Biovision |
|
EUR 713 |
) ExoStd? Lyophilized Exosome Standard (100 µg, Human Serum, 4 vials) |
|
M1043-4 |
Biovision |
|
EUR 1132 |
) ExoStd? Lyophilized Exosome Standard (100 µg, Human Serum, 6 vials) |
|
M1043-6 |
Biovision |
|
EUR 1572 |
) ExoStd? Lyophilized Exosome Standard (30 µg, Human Urine, 2 vials) |
|
M1044-2 |
Biovision |
|
EUR 599 |
) ExoStd? Lyophilized Exosome Standard (30 µg, Human Urine, 4 vials) |
|
M1044-4 |
Biovision |
|
EUR 909 |
) ExoStd? Lyophilized Exosome Standard (30 µg, Human Urine, 6 vials) |
|
M1044-6 |
Biovision |
|
EUR 1289 |
) ExoStd? Lyophilized Exosome Standard (100 µg, Human Urine, 2 vials) |
|
M1045-2 |
Biovision |
|
EUR 707 |
) ExoStd? Lyophilized Exosome Standard (100 µg, Human Urine, 4 vials) |
|
M1045-4 |
Biovision |
|
EUR 1137 |
) ExoStd? Lyophilized Exosome Standard (100 µg, Human Urine, 6 vials) |
|
M1045-6 |
Biovision |
|
EUR 1572 |
) ExoStd? Lyophilized Exosome Standard (30 µg, Human Saliva, 2 vials) |
|
M1046-2 |
Biovision |
|
EUR 604 |
) ExoStd? Lyophilized Exosome Standard (30 µg, Human Saliva, 4 vials) |
|
M1046-4 |
Biovision |
|
EUR 914 |
) ExoStd? Lyophilized Exosome Standard (30 µg, Human Saliva, 6 vials) |
|
M1046-6 |
Biovision |
|
EUR 1306 |
) ExoStd? Lyophilized Exosome Standard (100 µg, Human Saliva, 2 vials) |
|
M1047-2 |
Biovision |
|
EUR 729 |
) ExoStd? Lyophilized Exosome Standard (100 µg, Human Saliva, 4 vials) |
|
M1047-4 |
Biovision |
|
EUR 1137 |
) ExoStd? Lyophilized Exosome Standard (100 µg, Human Saliva, 6 vials) |
|
M1047-6 |
Biovision |
|
EUR 1621 |
) ExoStd? Lyophilized Exosome Standard (30 µg, U87 MG, 2 vials) |
|
M1054-2 |
Biovision |
|
EUR 604 |
) ExoStd? Lyophilized Exosome Standard (30 µg, U87 MG, 4 vials) |
|
M1054-4 |
Biovision |
|
EUR 914 |
) ExoStd? Lyophilized Exosome Standard (30 µg, U87 MG, 6 vials) |
|
M1054-6 |
Biovision |
|
EUR 1306 |
) ExoStd? Lyophilized Exosome Standard (100 µg, U87 MG, 2 vials) |
|
M1055-2 |
Biovision |
|
EUR 718 |
) ExoStd? Lyophilized Exosome Standard (100 µg, U87 MG, 4 vials) |
|
M1055-4 |
Biovision |
|
EUR 1142 |
) ExoStd? Lyophilized Exosome Standard (100 µg, U87 MG, 6 vials) |
|
M1055-6 |
Biovision |
|
EUR 1616 |
) Lyophilized Exosome Standard (Human Plasma) |
|
ESL-25 |
Creative Biolabs |
30 µgx2 vials |
EUR 1337 |
|
Description: Lyophilized exosomes can be used as control standards for FACS, WB, ELISA and as calibration standards for quantitation of exosome-derived markers from biological samples. |
) Lyophilized Exosome Standard (Human Saliva) |
|
ESL-27 |
Creative Biolabs |
30 µgx6 vials |
EUR 3023 |
|
Description: Lyophilized exosomes can be used as control standards for FACS, WB, ELISA and as calibration standards for quantitation of exosome-derived markers from biological samples. |
) Lyophilized Exosome Standard (Human Urine) |
|
ESL-29 |
Creative Biolabs |
30 µgx2 vials |
EUR 1350 |
|
Description: Lyophilized exosomes can be used as control standards for FACS, WB, ELISA and as calibration standards for quantitation of exosome-derived markers from biological samples. |
) Lyophilized Exosome Standard (Human Serum) |
|
ESL-32 |
Creative Biolabs |
30 µgx2 vials |
EUR 1350 |
|
Description: Lyophilized exosomes can be used as control standards for FACS, WB, ELISA and as calibration standards for quantitation of exosome-derived markers from biological samples. |
) ExoStd? Lyophilized Exosome Standard (30 µg, COLO1 cell line, 2 vials) |
|
M1048-2 |
Biovision |
|
EUR 604 |
) ExoStd? Lyophilized Exosome Standard (30 µg, COLO1 cell line, 4 vials) |
|
M1048-4 |
Biovision |
|
EUR 914 |
) ExoStd? Lyophilized Exosome Standard (30 µg, COLO1 cell line, 6 vials) |
|
M1048-6 |
Biovision |
|
EUR 1306 |
) ExoStd? Lyophilized Exosome Standard (100 µg, COLO1 cell line, 2 vials) |
|
M1049-2 |
Biovision |
|
EUR 718 |
) ExoStd? Lyophilized Exosome Standard (100 µg, COLO1 cell line, 4 vials) |
|
M1049-4 |
Biovision |
|
EUR 1142 |
) ExoStd? Lyophilized Exosome Standard (100 µg, COLO1 cell line, 6 vials) |
|
M1049-6 |
Biovision |
|
EUR 1616 |
) ExoStd? Lyophilized Exosome Standard (30 µg, MM1 cell line, 2 vials) |
|
M1050-2 |
Biovision |
|
EUR 604 |
) ExoStd? Lyophilized Exosome Standard (30 µg, MM1 cell line, 4 vials) |
|
M1050-4 |
Biovision |
|
EUR 914 |
) ExoStd? Lyophilized Exosome Standard (30 µg, MM1 cell line, 6 vials) |
|
M1050-6 |
Biovision |
|
EUR 1306 |
) ExoStd? Lyophilized Exosome Standard (100 µg, MM1 cell line, 2 vials) |
|
M1051-2 |
Biovision |
|
EUR 718 |
) ExoStd? Lyophilized Exosome Standard (100 µg, MM1 cell line, 4 vials) |
|
M1051-4 |
Biovision |
|
EUR 1142 |
) ExoStd? Lyophilized Exosome Standard (100 µg, MM1 cell line, 6 vials) |
|
M1051-6 |
Biovision |
|
EUR 1616 |
) ExoStd? Lyophilized Exosome Standard (30 µg, BLCL21 cell line, 2 vials) |
|
M1052-2 |
Biovision |
|
EUR 604 |
) ExoStd? Lyophilized Exosome Standard (30 µg, BLCL21 cell line, 4 vials) |
|
M1052-4 |
Biovision |
|
EUR 914 |
) ExoStd? Lyophilized Exosome Standard (30 µg, BLCL21 cell line, 6 vials) |
|
M1052-6 |
Biovision |
|
EUR 1306 |
) ExoStd? Lyophilized Exosome Standard (100 µg, BLCL21 cell line, 2 vials) |
|
M1053-2 |
Biovision |
|
EUR 718 |
) ExoStd? Lyophilized Exosome Standard (100 µg, BLCL21 cell line, 4 vials) |
|
M1053-4 |
Biovision |
|
EUR 1142 |
) ExoStd? Lyophilized Exosome Standard (100 µg, BLCL21 cell line, 6 vials) |
|
M1053-6 |
Biovision |
|
EUR 1572 |
) ExoStd? Lyophilized Exosome Standard (30 µg, HCT116 cell line, 2 vials) |
|
M1058-2 |
Biovision |
|
EUR 604 |
) ExoStd? Lyophilized Exosome Standard (30 µg, HCT116 cell line, 4 vials) |
|
M1058-4 |
Biovision |
|
EUR 914 |
) ExoStd? Lyophilized Exosome Standard (30 µg, HCT116 cell line, 6 vials) |
|
M1058-6 |
Biovision |
|
EUR 1306 |
) ExoStd? Lyophilized Exosome Standard (100 µg, HCT116 cell line, 2 vials) |
|
M1059-2 |
Biovision |
|
EUR 718 |
) ExoStd? Lyophilized Exosome Standard (100 µg, HCT116 cell line, 4 vials) |
|
M1059-4 |
Biovision |
|
EUR 1142 |
) ExoStd? Lyophilized Exosome Standard (100 µg, HCT116 cell line, 6 vials) |
|
M1059-6 |
Biovision |
|
EUR 1616 |
) ExoStd? Lyophilized Exosome Standard (30 µg, PC3 cell line, 2 vials) |
|
M1060-2 |
Biovision |
|
EUR 604 |
) ExoStd? Lyophilized Exosome Standard (30 µg, PC3 cell line, 4 vials) |
|
M1060-4 |
Biovision |
|
EUR 914 |
) ExoStd? Lyophilized Exosome Standard (30 µg, PC3 cell line, 6 vials) |
|
M1060-6 |
Biovision |
|
EUR 1306 |
) ExoStd? Lyophilized Exosome Standard (100 µg, PC3 cell line, 2 vials) |
|
M1061-2 |
Biovision |
|
EUR 718 |
) ExoStd? Lyophilized Exosome Standard (100 µg, PC3 cell line, 4 vials) |
|
M1061-4 |
Biovision |
|
EUR 1142 |
) ExoStd? Lyophilized Exosome Standard (100 µg, PC3 cell line, 6 vials) |
|
M1061-6 |
Biovision |
|
EUR 1616 |
) ExoStd? Lyophilized Exosome Standard (30 µg, DAUD1 cell line, 2 vials) |
|
M1064-2 |
Biovision |
|
EUR 604 |
) ExoStd? Lyophilized Exosome Standard (30 µg, DAUD1 cell line, 4 vials) |
|
M1064-4 |
Biovision |
|
EUR 914 |
) ExoStd? Lyophilized Exosome Standard (30 µg, DAUD1 cell line, 6 vials) |
|
M1064-6 |
Biovision |
|
EUR 1306 |
) ExoStd? Lyophilized Exosome Standard (100 µg, DAUD1 cell line, 2 vials) |
|
M1065-2 |
Biovision |
|
EUR 718 |
) ExoStd? Lyophilized Exosome Standard (100 µg, DAUD1 cell line, 4 vials) |
|
M1065-4 |
Biovision |
|
EUR 1142 |
) ExoStd? Lyophilized Exosome Standard (100 µg, DAUD1 cell line, 6 vials) |
|
M1065-6 |
Biovision |
|
EUR 1616 |
) ExoStd? Lyophilized Exosome Standard (30 µg, A549 cell line, 2 vials) |
|
M1066-2 |
Biovision |
|
EUR 604 |
) ExoStd? Lyophilized Exosome Standard (30 µg, A549 cell line, 4 vials) |
|
M1066-4 |
Biovision |
|
EUR 914 |
) ExoStd? Lyophilized Exosome Standard (30 µg, A549 cell line, 6 vials) |
|
M1066-6 |
Biovision |
|
EUR 1306 |
) ExoStd? Lyophilized Exosome Standard (100 µg, A549 cell line, 2 vials) |
|
M1067-2 |
Biovision |
|
EUR 718 |
) ExoStd? Lyophilized Exosome Standard (100 µg, A549 cell line, 4 vials) |
|
M1067-4 |
Biovision |
|
EUR 1142 |
) ExoStd? Lyophilized Exosome Standard (100 µg, A549 cell line, 6 vials) |
|
M1067-6 |
Biovision |
|
EUR 1616 |
) ExoStd? Lyophilized Exosome Standard (30 µg, B16F10 cell line, 2 vials) |
|
M1070-2 |
Biovision |
|
EUR 604 |
) ExoStd? Lyophilized Exosome Standard (30 µg, B16F10 cell line, 4 vials) |
|
M1070-4 |
Biovision |
|
EUR 914 |
) ExoStd? Lyophilized Exosome Standard (30 µg, B16F10 cell line, 6 vials) |
|
M1070-6 |
Biovision |
|
EUR 1306 |
) ExoStd? Lyophilized Exosome Standard (100 µg, B16F10 cell line, 2 vials) |
|
M1071-2 |
Biovision |
|
EUR 718 |
) ExoStd? Lyophilized Exosome Standard (100 µg, B16F10 cell line, 4 vials) |
|
M1071-4 |
Biovision |
|
EUR 1142 |
) ExoStd? Lyophilized Exosome Standard (1090 µg, B16F10 cell line, 6 vials) |
|
M1071-6 |
Biovision |
|
EUR 1616 |
 ExoStd? U87 MG Fluorescent Exosome Standard |
|
M1084-100 |
Biovision |
|
EUR 756 |
 ExoStd? BPH-1 Fluorescent Exosome Standard |
|
M1087-100 |
Biovision |
|
EUR 756 |
 ExoStd? K-562 Fluorescent Exosome Standard |
|
M1154-100 |
Biovision |
|
EUR 773 |
) ExoStd? Lyophilized Exosome Standard (30 µg, BPH-1 cell line, 2 vials) |
|
M1062-2 |
Biovision |
|
EUR 604 |
) ExoStd? Lyophilized Exosome Standard (30 µg, BPH-1 cell line, 4 vials) |
|
M1062-4 |
Biovision |
|
EUR 914 |
) ExoStd? Lyophilized Exosome Standard (30 µg, BPH-1 cell line, 6 vials) |
|
M1062-6 |
Biovision |
|
EUR 1306 |
) ExoStd? Lyophilized Exosome Standard (100 µg, BPH-1 cell line, 2 vials) |
|
M1063-2 |
Biovision |
|
EUR 718 |
) ExoStd? Lyophilized Exosome Standard (100 µg, BPH-1 cell line, 4 vials) |
|
M1063-4 |
Biovision |
|
EUR 1142 |
) ExoStd? Lyophilized Exosome Standard (100 µg, BPH-1 cell line, 6 vials) |
|
M1063-6 |
Biovision |
|
EUR 1616 |
) ExoStd? Lyophilized Exosome Standard (30 µg, K-562 cell line, 2 vials) |
|
M1068-2 |
Biovision |
|
EUR 604 |
) ExoStd? Lyophilized Exosome Standard (30 µg, K-562 cell line, 4 vials) |
|
M1068-4 |
Biovision |
|
EUR 914 |
) ExoStd? Lyophilized Exosome Standard (30 µg, K-562 cell line, 6 vials) |
|
M1068-6 |
Biovision |
|
EUR 1306 |
) ExoStd? Lyophilized Exosome Standard (100 µg, K-562 cell line, 2 vials) |
|
M1069-2 |
Biovision |
|
EUR 718 |
) ExoStd? Lyophilized Exosome Standard (100 µg, K-562 cell line, 4 vials) |
|
M1069-4 |
Biovision |
|
EUR 1142 |
) ExoStd? Lyophilized Exosome Standard (100 µg, K-562 cell line, 6 vials) |
|
M1069-6 |
Biovision |
|
EUR 1616 |
 ExoStd? SK-N-SH Fluorescent Exosome Standard |
|
M1085-100 |
Biovision |
|
EUR 756 |
) ExoStd? Lyophilized Exosome Standard (30 µg, SK-N-SH cell line, 2 vials) |
|
M1056-2 |
Biovision |
|
EUR 604 |
) ExoStd? Lyophilized Exosome Standard (30 µg, SK-N-SH cell line, 4 vials) |
|
M1056-4 |
Biovision |
|
EUR 914 |
) ExoStd? Lyophilized Exosome Standard (30 µg, SK-N-SH cell line, 6 vials) |
|
M1056-6 |
Biovision |
|
EUR 1306 |
) ExoStd? Lyophilized Exosome Standard (100 µg, SK-N-SH cell line, 2 vials) |
|
M1057-2 |
Biovision |
|
EUR 718 |
) ExoStd? Lyophilized Exosome Standard (100 µg, SK-N-SH cell line, 4 vials) |
|
M1057-4 |
Biovision |
|
EUR 1142 |
) ExoStd? Lyophilized Exosome Standard (100 µg, SK-N-SH cell line, 6 vials) |
|
M1057-6 |
Biovision |
|
EUR 1616 |
 Lyophilized Exosome Standards |
|
ExoA375 |
ImmunoStep |
100 μg |
EUR 303.5 |
Lyophilized Exosome Standards |
|
ExoHT29 |
ImmunoStep |
100 μg |
EUR 303.5 |
Lyophilized Exosome Standards |
|
ExoMCF7 |
ImmunoStep |
100 μg |
EUR 303.5 |
Lyophilized Exosome Standards |
|
ExoPC3 |
ImmunoStep |
100 μg |
EUR 303.5 |
Lyophilized Exosome Standards |
|
ExoPLASMA |
ImmunoStep |
100 μg |
EUR 303.5 |
Lyophilized Exosome Standards |
|
ExoUrine |
ImmunoStep |
100 μg |
EUR 303.5 |
 Lyophilized recombinant standard |
|
ST0000-1 |
BosterBio |
1ng/vial |
EUR 172 |
Lyophilized recombinant standard |
|
ST0000-10 |
BosterBio |
10ng/vial |
EUR 172 |
Lyophilized recombinant standard |
|
ST0000-100 |
BosterBio |
100ng/vial |
EUR 172 |
Lyophilized recombinant standard |
|
ST0000-20 |
BosterBio |
20ng/vial |
EUR 172 |
Lyophilized recombinant standard |
|
ST0000-4 |
BosterBio |
4ng/vial |
EUR 172 |
Lyophilized recombinant standard |
|
ST0000-50 |
BosterBio |
50ng/vial |
EUR 172 |
) Fluorescent Exosome Standard (Urine ) |
|
ESF-15 |
Creative Biolabs |
100 µg |
EUR 1723 |
|
Description: Fluorescent exosomes are labeled with green dye, which offer a stable fluorescent labeling. |
 Standard) Exo-Check Exosome Antibody Array (Neuro) Standard |
|
EXORAY500A-4 |
SBI |
4 arrays |
EUR 690 |
Exo-Check Exosome Antibody Array (Neuro) Standard |
|
EXORAY500A-8 |
SBI |
8 arrays |
EUR 1159 |
, tested for complement activity) Standard Rabbit Complement serum (Lyophilized), tested for complement activity |
|
COMPR-2 |
Alpha Diagnostics |
2 ml |
EUR 286 |
Standard Rabbit Complement serum (Lyophilized), tested for complement activity |
|
COMPR-20 |
Alpha Diagnostics |
20 ml |
EUR 408 |
Standard Rabbit Complement serum (Lyophilized), tested for complement activity |
|
COMPR-5 |
Alpha Diagnostics |
5 ml |
EUR 286 |
, tested for complement activity) Standard G. Pig Complement serum (Lyophilized), tested for complement activity |
|
COMPG-1 |
Alpha Diagnostics |
1 ml |
EUR 225 |
Standard G. Pig Complement serum (Lyophilized), tested for complement activity |
|
COMPG-5 |
Alpha Diagnostics |
5 ml |
EUR 286 |
 Streptavidin, Lyophilized |
|
S0819-002 |
GenDepot |
2mg |
EUR 286 |
Streptavidin, Lyophilized |
|
S0819-010 |
GenDepot |
10mg |
EUR 415 |
 Lyophilized Platelets |
|
ABP-LYO-PLT |
Abpcorp |
3 x 4ml vials |
EUR 128 |
 Standard |
|
abx092106-1vial |
Abbexa |
1 vial |
EUR 217 |
|
|
Standard |
|
abx098954-10vials |
Abbexa |
10 vials |
EUR 2179 |
|
|
Standard |
|
abx098954-1vial |
Abbexa |
1 vial |
EUR 300 |
|
|
Standard |
|
abx098954-5vials |
Abbexa |
5 vials |
EUR 1177 |
|
|
Standard |
|
abx098955-10vials |
Abbexa |
10 vials |
EUR 2179 |
|
|
Standard |
|
abx098955-1vial |
Abbexa |
1 vial |
EUR 300 |
|
|
Standard |
|
abx098955-5vials |
Abbexa |
5 vials |
EUR 1177 |
|
|
Standard |
|
abx098956-10vials |
Abbexa |
10 vials |
EUR 2179 |
|
|
Standard |
|
abx098956-1vial |
Abbexa |
1 vial |
EUR 300 |
|
|
Standard |
|
abx098956-5vials |
Abbexa |
5 vials |
EUR 1177 |
|
|
Standard |
|
abx098963-10vials |
Abbexa |
10 vials |
EUR 2179 |
|
|
Standard |
|
abx098963-1vial |
Abbexa |
1 vial |
EUR 300 |
|
|
Standard |
|
abx098963-5vials |
Abbexa |
5 vials |
EUR 1177 |
|
|
Standard |
|
abx098965-10vials |
Abbexa |
10 vials |
EUR 2179 |
|
|
Standard |
|
abx098965-1vial |
Abbexa |
1 vial |
EUR 300 |
|
|
Standard |
|
abx098965-5vials |
Abbexa |
5 vials |
EUR 1177 |
|
|
Standard |
|
abx098967-10vials |
Abbexa |
10 vials |
EUR 2179 |
|
|
Standard |
|
abx098967-1vial |
Abbexa |
1 vial |
EUR 300 |
|
|
Standard |
|
abx098967-5vials |
Abbexa |
5 vials |
EUR 1177 |
|
|
Standard |
|
abx098968-10vials |
Abbexa |
10 vials |
EUR 2179 |
|
|
Standard |
|
abx098968-1vial |
Abbexa |
1 vial |
EUR 300 |
|
|
Standard |
|
abx098968-5vials |
Abbexa |
5 vials |
EUR 1177 |
|
|
Standard |
|
abx098969-10vials |
Abbexa |
10 vials |
EUR 2179 |
|
|
Standard |
|
abx098969-1vial |
Abbexa |
1 vial |
EUR 300 |
|
|
Standard |
|
abx098969-5vials |
Abbexa |
5 vials |
EUR 1177 |
|
|
Standard |
|
abx296006-1vial |
Abbexa |
1 vial |
EUR 300 |
|
|
 Psoriasis Exosome |
|
P141-PS |
101Bio |
- |
Ask for price |
 CORNING® PRIMARIA™ 60MM STANDARD CELL CULTURE DISH, 20/PACK, 200/CASE |
|
353802 |
CORNING |
20/pk |
EUR 143 |
|
Description: Advanced Cells - DL; Primaria |
 Bevacizumab Lyophilized powder |
|
B077-5MG |
TOKU-E |
5 mg |
EUR 410 |
) Protein A (Lyophilized) |
|
6500B-10 |
Biovision |
|
EUR 147 |
Protein A (Lyophilized) |
|
6500B-100 |
Biovision |
|
EUR 697 |
Protein A (Lyophilized) |
|
6500B-1000 |
Biovision |
|
EUR 1784 |
Protein A (Lyophilized) |
|
6500B-25 |
Biovision |
|
EUR 251 |
Protein A (Lyophilized) |
|
6500B-5000 |
Biovision |
|
Ask for price |
Use could be made of medical college students within the transmission of correct info during the COVID-19 pandemic. Students could be wonderful activists on these topics in international locations by which medical education is suspended. Measures subsequently have to be taken in regards to the transmission of updated and correct info to medical college students.
